Halozyme Therapeutics | GJELD

Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amarin USD 0 0 2022-06
Amgen USD 64.61B 4.15B 2023-12
Baxter International USD 13.8B 2.7B 2023-12
Cytokinetics USD 618.45M 9.43M 2023-12
DBV Technologies USD 0 0 2022-06
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
MannKind USD 518.64M 141.28M 2023-12
Pfizer USD 63.6B 1.74B 2023-09
United Therapeutics USD 700M 100M 2023-12



Halozyme Therapeutics GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.